genes

NFE2L2

NFE2L2 (NRF2) is the master regulator of the cells antioxidant response and detoxification system. It serves as a molecular "security guard" that senses oxidative stress and environmental toxins, triggering the expression of over 200 protective genes; its decline is a core driver of age-related disease and neurodegeneration, while its hyperactivation can protect cancer cells from treatment.

schedule 8 min read update Updated February 28, 2026

Key Takeaways

  • NRF2 is the cells master switch for antioxidant defense, turning on the production of glutathione and other protective enzymes.
  • It is regulated by a "hinge-and-latch" mechanism with KEAP1, which keeps NRF2 suppressed until a stress signal is detected.
  • Dietary electrophiles like sulforaphane (from broccoli sprouts) are the most potent natural activators of the NRF2 system.
  • Age-related NRF2 decline leads to a "blunted" stress response, allowing oxidative damage to accumulate in the brain and heart.
  • In established cancers, NRF2 can be hijacked by the tumor to resist radiation and chemotherapy, acting as a "dark side" survival factor.

Basic Information

Gene Symbol
NFE2L2
Full Name
Nuclear Factor, Erythroid 2 Like 2
Also Known As
NRF2HEBP1
Location
2q31.2
Protein Type
Transcription factor
Protein Family
Basic Leucine Zipper (bZIP)

Related Isoforms

NRF2 Isoform 1

The canonical full-length protein containing all transactivation and binding domains.

Key SNPs

rs6721961 Promoter

The -617C/A variant; A allele reduces NRF2 expression and is linked to increased cancer and lung risk.

rs35652124 Promoter

The -653G/A variant; associated with age at onset in Parkinsons and cardiovascular mortality.

rs10183914 Intronic

Regulatory variant linked to neurodegenerative outcomes and stroke recovery.

rs6726395 Intronic

Associated with lung function decline and emphysema-associated aging in smokers.

rs2364723 Intronic

Protective variant associated with reduced all-cause and cardiovascular mortality.

rs1806649 Intronic

Protective variant linked to reduced COPD risk and delayed Parkinsons onset.

Overview

NFE2L2 (Nuclear Factor, Erythroid 2 Like 2), more commonly known as NRF2, is the cellular "security guard." Its primary job is to orchestrate the defense against oxidative stress, environmental toxins, and metabolic waste. Under normal conditions, NRF2 is kept in check by a partner protein called KEAP1, which traps it in the cytoplasm and targets it for constant destruction.

When the cell senses stress—be it from reactive oxygen species (ROS), heavy metals, or certain dietary compounds—the bond between NRF2 and KEAP1 is broken. This allows NRF2 to surge into the nucleus and turn on the Antioxidant Response Element (ARE), a master key that unlocks over 200 genes involved in cleanup and repair. Because it protects against the random damage that drives aging, NRF2 is considered a cornerstone of species longevity.

Conceptual Model

A simplified mental model for the pathway:

KEAP1
The Anchor
Holds NRF2 back
ROS
The Signal
Triggers release
ARE
The Master Key
DNA binding site
GSH
The Shield
Primary output

The system is designed for rapid response to local stress, not permanent activation.

Core Health Impacts

  • Oxidative Shield: Neutralizes reactive oxygen and nitrogen species before they damage DNA.
  • Toxin Clearance: Increases the detoxification of heavy metals and environmental carcinogens.
  • Mito Support: Enhances mitochondrial biogenesis and the efficiency of energy production.
  • Waste Disposal: Promotes the cleanup of misfolded proteins through the proteasome and autophagy.
  • Biosynthesis: Regulates the Pentose Phosphate Pathway to provide biosynthetic power for repair.
  • Genome Guard: Supports DNA repair machinery and maintains overall genomic stability.

Protein Domains

Neh2 Domain

The interaction site for KEAP1. Contains motifs that act as the "hinge and latch" for control.

bZIP Domain

The "business end" that binds to DNA at ARE sequences after pairing with small Maf proteins.

Neh4/5 Domains

Transactivation domains that recruit co-activators to start reading defense genes.

Upstream Regulators

KEAP1 Inhibitor

Primary negative regulator; sequesters NRF2 in cytoplasm and targets it for degradation.

Oxidative Stress / ROS Activator

Modifies cysteine residues on KEAP1, preventing NRF2 ubiquitination and allowing nuclear entry.

Electrophiles Activator

Dietary compounds like sulforaphane that poison KEAP1, triggering a potent response.

p62 (SQSTM1) Activator

Autophagy adapter that competes with NRF2 for KEAP1 binding; links recycling to redox defense.

PI3K / AKT Activator

Promotes NRF2 nuclear localization through phosphorylation and KEAP1-independent pathways.

Bach1 Inhibitor

Transcription factor that competes with NRF2 for binding to Antioxidant Response Elements (AREs).

Downstream Targets

HMOX1 (HO-1) Activates

Heme oxygenase-1; breaks down heme into carbon monoxide and the antioxidant biliverdin.

NQO1 Activates

NAD(P)H quinone dehydrogenase 1; prevents the formation of ROS from quinones.

GCLC / GCLM Activates

Rate-limiting enzymes for glutathione (GSH) synthesis, the cells primary internal shield.

TXNRD1 Activates

Thioredoxin reductase 1; essential for maintaining proteins in a functional, reduced state.

SLC7A11 Activates

Cystine/glutamate transporter; provides the cysteine required for glutathione production.

GSTs Activates

Glutathione S-transferases; phase II detoxification enzymes that conjugate toxins for excretion.

Role in Aging

NRF2 is a primary determinant of healthspan. As we age, the NRF2 response becomes "blunted"—it takes more stress to activate the system, and the response is weaker, contributing to the hallmark of proteostasis loss.

Antioxidant Capacity

The age-related decline in NRF2 reduces glutathione levels, allowing oxidative damage to accumulate in DNA and lipids.

Mitochondrial Decay

NRF2 supports mitochondrial biogenesis. Its decline leads to "leaky" mitochondria that produce more ROS and less ATP.

Proteostasis Failure

By regulating the proteasome, NRF2 prevents the buildup of "cellular junk" like beta-amyloid in aging brains.

Inflammaging

NRF2 antagonizes the NF-κB pathway. When NRF2 is low, chronic low-grade inflammation is allowed to persist.

Stem Cell Resilience

High NRF2 levels are required to maintain the regenerative potential of stem cells, ensuring tissue repair.

Species Longevity

Long-lived species like the naked mole rat exhibit high baseline NRF2 activity, a secret to extreme survival.

Disorders & Diseases

Neurodegenerative Disease

The brain is highly susceptible to oxidative stress. NRF2 failure is a defining hallmark of Alzheimer, Parkinson, and ALS.

Alzheimer: Nuclear NRF2 is depleted in hippocampal neurons.
Parkinson: Genetic variants are linked to significantly earlier onset.

Cancer: The Dark Side

While NRF2 prevents early mutations, many established tumors hijack the pathway to resist radiation and chemotherapy.

Cardiometabolic Health

NRF2 protects the vessel lining (endothelium) from glucose-induced damage, reducing atherosclerosis risk.

Chronic Kidney Disease

NRF2 activation is a major therapeutic target for slowing the progression of kidney failure.

Interventions

Supplements

Sulforaphane

Found in broccoli sprouts; the most potent natural inducer of NRF2 through KEAP1 modification.

Curcumin

Turmeric polyphenol that activates NRF2 signaling and reduces systemic inflammation.

Resveratrol

Activates NRF2 alongside SIRT1, supporting mitochondrial health and antioxidant defenses.

EGCG

Green tea catechin that stimulates the NRF2 pathway and protects against oxidative DNA damage.

Milk Thistle (Silybin)

Traditionally used for liver support; acts in part through NRF2-mediated detoxification.

Lifestyle

Regular Exercise

Transiently increases ROS, which "trains" the NRF2 system to increase baseline capacity (hormesis).

Sauna / Heat Stress

The heat shock response cross-talks with NRF2, enhancing cellular resilience and proteostasis.

Intermittent Fasting

Nutrient deprivation triggers autophagy (p62), which stabilizes NRF2 by inhibiting KEAP1.

Cold Exposure

Activates metabolic pathways that intersect with NRF2 to manage thermal stress and redox balance.

Medicines

Dimethyl Fumarate (Tecfidera)

FDA-approved for Multiple Sclerosis; a potent NRF2 activator that reduces neuroinflammation.

Bardoxolone Methyl

Investigational NRF2 activator studied for chronic kidney disease and pulmonary hypertension.

Metformin

Can activate NRF2 through AMPK signaling, contributing to its anti-aging effects.

Statins

Reported to have pleiotropic effects on NRF2 activity, supporting endothelial health.

Lab Tests & Biomarkers

Genetic Testing

Promoter SNP rs6721961

A allele indicates lower baseline NRF2 expression and higher cancer risk.

PD-Risk SNP rs35652124

Useful for assessing neurodegenerative and stroke risk profiles.

Activity Markers

8-OHdG

Urinary marker of oxidative DNA damage; high levels suggest NRF2 insufficiency.

GSH / GSSG Ratio

Measures the "bank account" of reduced vs oxidized glutathione in the cell.

Functional Markers

Serum GGT

High levels can be a proxy for glutathione depletion and chronic NRF2 stress.

Hormonal Interactions

Melatonin Synergistic Activator

Directly upregulates NRF2 expression and activity, particularly in the brain during sleep.

Estrogen Modulator

Interacts with ARE-mediated signaling; loss during menopause can dampen NRF2 defenses.

Melanocyte-Stimulating Hormone Protective Partner

Coordinates with NRF2 in the skin to protect against UV-induced oxidative damage.

Thyroid Hormones Metabolic Driver

Increase metabolic rate and ROS production, necessitating NRF2-mediated balancing.

Deep Dive

Network Diagrams

NRF2 Activation Mechanism

The p62-KEAP1-NRF2 Regulatory Loop

The Hinge-and-Latch: How KEAP1 Controls NRF2

The relationship between NRF2 and its inhibitor, KEAP1, is one of the most elegant sensors in biology. KEAP1 acts as a “molecular sensor” using specialized sulfur-containing amino acids (cysteines) that react to oxidative stress.

  • The Latch (ETGE): Under normal conditions, KEAP1 binds NRF2 at two points. One is a high-affinity “hinge” and the other is a lower-affinity “latch.” This configuration allows KEAP1 to constantly feed NRF2 into the cellular “trash compactor” (the proteasome), keeping levels extremely low.
  • The Release: When oxidative stress or electrophiles (like sulforaphane) appear, they modify the KEAP1 cysteines, causing the “latch” to pop open. NRF2 can no longer be degraded, so it accumulates, floods the nucleus, and activates the defense program.

Feedback Loops: The Autophagy-Redox Connection

NRF2 doesnt work in isolation; it is deeply integrated with the cells recycling system (autophagy). A key player here is a protein called p62.

  • The p62 Loop: When a cell has too much “cellular junk” (damaged proteins or organelles), p62 levels rise to mark them for destruction. Crucially, p62 also binds to KEAP1 at the same spot NRF2 does. By “stealing” KEAP1, p62 allows NRF2 to activate even in the absence of oxidative stress.
  • Outcome: This creates a powerful feedback loop: autophagy stress activates NRF2, and NRF2 in turn activates more autophagy genes, ensuring the cell can handle the metabolic burden of cleaning itself up.

The “Blunted” Response in Aging

In youthful cells, the NRF2 “security guard” is hyper-vigilant. However, research shows that as organisms age, the NRF2 response becomes blunt. It takes a much larger “fire” of oxidative stress to trigger the same defensive response.

This blunting is a core driver of the hallmarks of aging. Without NRF2 to maintain glutathione levels and proteasome activity, the cell becomes increasingly polluted with damaged molecules, leading to the cellular “constipation” seen in neurodegenerative diseases like Alzheimer.

Managing the NRF2 Thermostat

Hormetic Triggers. Brief pulses of stress (like high-intensity exercise or broccoli sprouts) keep the NRF2 system primed and responsive.

Avoid Chronic Activation. Permanent NRF2 activation is associated with cancer risk; the goal is high sensitivity, not constant high output.

Relevant Research Papers

Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.

Itoh et al. (1997) Biochemical and Biophysical Research Communications

The foundational discovery paper identifying NRF2 as a transcription factor for antioxidants.

Lewis et al. (2010) Ageing Research Reviews

Seminal review establishing NRF2 as a central regulator of longevity and disease resistance.

Wang et al. (2008) Carcinogenesis

First major paper detailing how NRF2 hyperactivation protects malignant cells from treatment.

Ramos-Gomez et al. (2001) PNAS
PubMed Free article DOI

Demonstrated that NRF2 deficiency leads to extreme susceptibility to chemical carcinogens.

Ramsey et al. (2007) Journal of Neuropathology & Experimental Neurology

Showed that NRF2 nuclear localization is impaired in AD neurons despite high oxidative stress.

DeNicola et al. (2011) Nature

Established that K-Ras and B-Raf oncogenes actively hijack NRF2 to support tumor growth.